{"transactions":[{"id":4639711,"issuer":{"id":7263,"kind":"organization","name":"Xos, Inc.","symbol":"XOS"},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-10-13T21:39:00.000Z","date":"2026-10-10","kind":"grant","planned":false,"acquired":true,"shares":1814,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares reported in this transaction represent RSUs that were issued to the Reporting Person in lieu of the cash retainer for the Reporting Person's service as a non-emolpyee director in Q3 2026. The RSUs reported vested immediately on the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 60,584 unvested RSUs."}],"balance_after":196428,"source":{"system":"sec-edgar","filing":"0001193125-26-420688","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819493/000119312526420688/ownership.xml","form_type":"4"}},{"id":4634026,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2026-10-03T01:00:07.000Z","date":"2026-09-30","kind":"grant","planned":false,"acquired":true,"shares":129,"price":261.59,"value":33745.11,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under the director's grantor trust are distributed over a period equal to the director's years of board service, generally commencing at the later of age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under the director's grantor trust are distributed over a period equal to the director's years of board service, generally commencing at the later of age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":29568,"derivative":{"exercise_price":261.59,"underlying":"Common Stock","underlying_shares":129},"source":{"system":"sec-edgar","filing":"0001171780-26-000014","document":"form4-10022026_051002.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000117178026000014/form4-10022026_051002.xml","form_type":"4"}},{"id":709962,"issuer":{"id":7263,"kind":"organization","name":"Xos, Inc.","symbol":"XOS"},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-14T22:03:00.000Z","date":"2026-07-10","kind":"grant","planned":false,"acquired":true,"shares":60584,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The shares reported in this transaction represent Restricted Stock Units (\"RSUs\"), each of which represents a contingent right to receive one share of the Issuer's common stock upon settlement. The RSUs vest on the earlier of (i) the first anniversary of the Grant date and (ii) the day before the Company's 2027 Annual Meeting, subject to the Reporting Person's continuous service with Xos, Inc. through the vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 60,584 unvested RSUs"}],"balance_after":194614,"source":{"system":"sec-edgar","filing":"0001193125-26-303481","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000119312526303481/ownership.xml","form_type":"4"}},{"id":709961,"issuer":{"id":7263,"kind":"organization","name":"Xos, Inc.","symbol":"XOS"},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-14T22:03:00.000Z","date":"2026-07-10","kind":"grant","planned":false,"acquired":true,"shares":2670,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares reported in this transaction represent RSUs that were issued to the Reporting Person in lieu of the cash retainer for the Reporting Person's service as a non-employee director and as Audit Committee Chair in the second quarter of 2026. The RSUs reported vested immediately on the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 60,584 unvested RSUs"}],"balance_after":134030,"source":{"system":"sec-edgar","filing":"0001193125-26-303481","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000119312526303481/ownership.xml","form_type":"4"}},{"id":7084,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2026-07-02T21:00:14.000Z","date":"2026-06-30","kind":"grant","planned":false,"acquired":true,"shares":134,"price":251.64,"value":33719.76,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under the director's grantor trust are distributed over a period equal to the director's years of board service, generally commencing at the later of age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under the director's grantor trust are distributed over a period equal to the director's years of board service, generally commencing at the later of age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":29236,"derivative":{"exercise_price":251.64,"underlying":"Common Stock","underlying_shares":134},"source":{"system":"sec-edgar","filing":"0001171780-26-000012","document":"form4-07022026_050703.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000117178026000012/form4-07022026_050703.xml","form_type":"4"}},{"id":9918,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.01 par value","published_at":"2026-05-12T21:00:25.000Z","date":"2026-05-08","kind":"grant","planned":false,"acquired":true,"shares":1118,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These are restricted stock units awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program (the \"Program\"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Total holdings include 10,388 shares in trust previously held indirectly by spouse, now held directly."}],"balance_after":45964,"source":{"system":"sec-edgar","filing":"0001171780-26-000010","document":"form4-05122026_050518.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000117178026000010/form4-05122026_050518.xml","form_type":"4"}},{"id":809031,"issuer":{"id":7263,"kind":"organization","name":"Xos, Inc.","symbol":"XOS"},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-14T22:03:23.000Z","date":"2026-04-10","kind":"grant","planned":false,"acquired":true,"shares":5182,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares reported in this transaction represent RSUs that were issued to the Reporting Person in lieu of the cash retainer for the Reporting Person's service as Audit Committee Chair and a Director in the first quarter of 2026. The RSUs reported vested immediately on the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 62,377 unvested RSUs."}],"balance_after":131360,"source":{"system":"sec-edgar","filing":"0001171780-26-000008","document":"wk-form4_1776204201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000117178026000008/wk-form4_1776204201.xml","form_type":"4"}},{"id":11003,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2026-04-02T21:00:14.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":155,"price":217.49,"value":33710.95,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":28865,"derivative":{"exercise_price":217.49,"underlying":"Common Stock","underlying_shares":155},"source":{"system":"sec-edgar","filing":"0001171780-26-000006","document":"form4-04022026_050408.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000117178026000006/form4-04022026_050408.xml","form_type":"4"}},{"id":940229,"issuer":{"id":7263,"kind":"organization","name":"Xos, Inc.","symbol":"XOS"},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-14T00:53:09.000Z","date":"2026-01-10","kind":"grant","planned":false,"acquired":true,"shares":2401,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares reported in this transaction represent RSUs that were issued to the Reporting Person in lieu of the cash retainer for the Reporting Person's service as Audit Committee Chair in the fourth quarter of 2025. The RSUs reported vested immediately on the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 62,377 unvested RSUs."}],"balance_after":126178,"source":{"system":"sec-edgar","filing":"0001171780-26-000004","document":"wk-form4_1768351987.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000117178026000004/wk-form4_1768351987.xml","form_type":"4"}},{"id":15635,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2026-01-05T22:00:10.000Z","date":"2025-12-31","kind":"grant","planned":false,"acquired":true,"shares":147,"price":228.49,"value":33588.03,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":28498,"derivative":{"exercise_price":228.49,"underlying":"Common Stock","underlying_shares":147},"source":{"system":"sec-edgar","filing":"0001171780-26-000002","document":"form4-01052026_050107.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000117178026000002/form4-01052026_050107.xml","form_type":"4"}},{"id":1019523,"issuer":{"id":7263,"kind":"organization","name":"Xos, Inc.","symbol":"XOS"},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-14T20:59:44.000Z","date":"2025-10-10","kind":"grant","planned":false,"acquired":true,"shares":1883,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares reported in this transaction represent RSUs that were issued to the Reporting Person in lieu of the cash retainer for the Reporting Person's service as Audit Committee Chair in Q3 2025. The RSUs reported vested immediately on the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 62,377 unvested RSUs."}],"balance_after":123777,"source":{"system":"sec-edgar","filing":"0001171780-25-000006","document":"wk-form4_1760475582.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000117178025000006/wk-form4_1760475582.xml","form_type":"4"}},{"id":18891,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2025-10-02T21:00:12.000Z","date":"2025-09-30","kind":"grant","planned":false,"acquired":true,"shares":145,"price":231.54,"value":33573.3,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":28152,"derivative":{"exercise_price":231.54,"underlying":"Common Stock","underlying_shares":145},"source":{"system":"sec-edgar","filing":"0001171780-25-000004","document":"form4-10022025_051003.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000117178025000004/form4-10022025_051003.xml","form_type":"4"}},{"id":1088161,"issuer":{"id":7263,"kind":"organization","name":"Xos, Inc.","symbol":"XOS"},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-14T20:32:59.000Z","date":"2025-07-10","kind":"grant","planned":false,"acquired":true,"shares":1601,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The shares reported in this transaction represent RSUs that were issued to the Reporting Person in lieu of the cash retainer for the Reporting Person's service as Audit Committee Chair in Q2 2025. The RSUs reported vested immediately on the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 62,377 unvested RSUs."}],"balance_after":121894,"source":{"system":"sec-edgar","filing":"0001819493-25-000101","document":"wk-form4_1752525169.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000181949325000101/wk-form4_1752525169.xml","form_type":"4"}},{"id":1088160,"issuer":{"id":7263,"kind":"organization","name":"Xos, Inc.","symbol":"XOS"},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-14T20:32:59.000Z","date":"2025-07-10","kind":"grant","planned":false,"acquired":true,"shares":62377,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares reported in this transaction represent Restricted Stock Units (\"RSUs\"), each of which represents a contingent right to receive one share of the Issuer's common stock upon settlement. The RSUs vest on the earlier of (i) the first anniversary of the Grant date and (ii) the day before the Company's 2026 Annual Meeting, subject to the Reporting Person's continuous service with Xos, Inc. through the vesting date"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 62,377 unvested RSUs."}],"balance_after":120293,"source":{"system":"sec-edgar","filing":"0001819493-25-000101","document":"wk-form4_1752525169.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000181949325000101/wk-form4_1752525169.xml","form_type":"4"}},{"id":22042,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2025-07-02T21:00:10.000Z","date":"2025-06-30","kind":"grant","planned":false,"acquired":true,"shares":177,"price":185.62,"value":32854.74,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":27785,"derivative":{"exercise_price":185.62,"underlying":"Common Stock","underlying_shares":177},"source":{"system":"sec-edgar","filing":"0001415889-25-019107","document":"form4-07022025_050706.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000141588925019107/form4-07022025_050706.xml","form_type":"4"}},{"id":24078,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.01 par value","published_at":"2025-05-13T21:05:04.000Z","date":"2025-05-09","kind":"grant","planned":false,"acquired":true,"shares":1203,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These are restricted stock units awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program (the \"Program\"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an additional 1,899 shares which, due to an administrative error, were inadvertently omitted from a previously filed form."}],"balance_after":34458,"source":{"system":"sec-edgar","filing":"0001415889-25-012792","document":"form4-05132025_050501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000141588925012792/form4-05132025_050501.xml","form_type":"4"}},{"id":1163501,"issuer":{"id":7263,"kind":"organization","name":"Xos, Inc.","symbol":"XOS"},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-30T23:30:08.000Z","date":"2025-04-10","kind":"grant","planned":false,"acquired":true,"shares":1407,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares reported in this transaction represent Restricted Stock Units (\"RSUs\"), each of which represents a contingent right to receive one share of the Issuer's common stock upon settlement and were issued to the director in lieu of their cash retainer for the director's service as in Q1 2025. The RSUs reported vested immediately on the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 28,694 unvested RSUs."}],"balance_after":57916,"source":{"system":"sec-edgar","filing":"0001819493-25-000056","document":"wk-form4_1746055802.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000181949325000056/wk-form4_1746055802.xml","form_type":"4"}},{"id":25227,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2025-04-02T21:00:13.000Z","date":"2025-03-31","kind":"grant","planned":false,"acquired":true,"shares":155,"price":209.52,"value":32475.6,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":27361,"derivative":{"exercise_price":209.52,"underlying":"Common Stock","underlying_shares":155},"source":{"system":"sec-edgar","filing":"0001415889-25-009690","document":"form4-04022025_050409.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000141588925009690/form4-04022025_050409.xml","form_type":"4"}},{"id":1243715,"issuer":{"id":7263,"kind":"organization","name":"Xos, Inc.","symbol":"XOS"},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-26T21:22:34.000Z","date":"2025-01-10","kind":"grant","planned":false,"acquired":true,"shares":1475,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares reported in this transaction represent Restricted Stock Units (\"RSUs\"), each of which represents a contingent right to receive one share of the Issuer's common stock upon settlement and were issued to the Reporting Person in lieu of their cash retainer for the director service in Q4 2024. The RSUs reported vested immediately on the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 28,694 unvested RSUs."}],"balance_after":56509,"source":{"system":"sec-edgar","filing":"0001819493-25-000029","document":"wk-form4a_1740604946.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000181949325000029/wk-form4a_1740604946.xml","form_type":"4/A","original_submission_date":"2025-01-14"}},{"id":1303714,"issuer":{"id":7263,"kind":"organization","name":"Xos, Inc.","symbol":"XOS"},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-15T02:43:25.000Z","date":"2025-01-10","kind":"grant","planned":false,"acquired":true,"shares":1065,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares reported in this transaction represent Restricted Stock Units (\"RSUs\"), each of which represents a contingent right to receive one share of the Issuer's common stock upon settlement and were issued to the Reporting Person in lieu of their cash retainer for the director service in Q4 2024. The RSUs reported vested immediately on the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 28,694 unvested RSUs."}],"balance_after":56099,"source":{"system":"sec-edgar","filing":"0001819493-25-000010","document":"wk-form4_1736908999.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000181949325000010/wk-form4_1736908999.xml","form_type":"4"}},{"id":30893,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2025-01-03T22:00:08.000Z","date":"2024-12-31","kind":"grant","planned":false,"acquired":true,"shares":182,"price":177.7,"value":32341.4,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":26976,"derivative":{"exercise_price":177.7,"underlying":"Common Stock","underlying_shares":182},"source":{"system":"sec-edgar","filing":"0001415889-25-000520","document":"form4-01032025_050105.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000141588925000520/form4-01032025_050105.xml","form_type":"4"}},{"id":1329376,"issuer":{"id":7263,"kind":"organization","name":"Xos, Inc.","symbol":"XOS"},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-17T20:17:35.000Z","date":"2024-10-10","kind":"grant","planned":false,"acquired":true,"shares":1065,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares reported in this transaction represent Restricted Stock Units (\"RSUs\"), each of which represents a contingent right to receive one share of the Issuer's common stock upon settlement and were issued to the director in lieu of their cash retainer for the director's service in Q3 2024. The RSUs reported vested immediately on the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 28,694 unvested RSUs."}],"balance_after":55034,"source":{"system":"sec-edgar","filing":"0001819493-24-000206","document":"wk-form4_1734466648.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000181949324000206/wk-form4_1734466648.xml","form_type":"4"}},{"id":35039,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2024-10-02T21:00:16.000Z","date":"2024-09-30","kind":"grant","planned":false,"acquired":true,"shares":164,"price":197.48,"value":32386.72,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":26544,"derivative":{"exercise_price":197.48,"underlying":"Common Stock","underlying_shares":164},"source":{"system":"sec-edgar","filing":"0001415889-24-024453","document":"form4-10022024_051010.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000141588924024453/form4-10022024_051010.xml","form_type":"4"}},{"id":1455474,"issuer":{"id":7263,"kind":"organization","name":"Xos, Inc.","symbol":"XOS"},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-13T00:21:27.000Z","date":"2024-07-10","kind":"grant","planned":false,"acquired":true,"shares":717,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents RSUs issued to the director in lieu of their cash retainer for the director's service in Q2 2024. The RSUs reported vested immediately on the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 29,330 unvested RSUs."}],"balance_after":53969,"source":{"system":"sec-edgar","filing":"0001819493-24-000115","document":"wk-form4_1720830081.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000181949324000115/wk-form4_1720830081.xml","form_type":"4"}},{"id":1455473,"issuer":{"id":7263,"kind":"organization","name":"Xos, Inc.","symbol":"XOS"},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-13T00:21:27.000Z","date":"2024-07-10","kind":"grant","planned":false,"acquired":true,"shares":28694,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares reported in this transaction represent Restricted Stock Units (\"RSUs\"), each of which represents a contingent right to receive one share of the Issuer's common stock upon settlement. The RSUs vest on the earlier of (i) the first anniversary of the Grant date and (ii) the day of the Company's 2025 Annual Meeting, subject to the Reporting Person's continuous service with Xos, Inc. through the vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 29,330 unvested RSUs."}],"balance_after":53252,"source":{"system":"sec-edgar","filing":"0001819493-24-000115","document":"wk-form4_1720830081.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000181949324000115/wk-form4_1720830081.xml","form_type":"4"}},{"id":38650,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true}}],"security":"Stock Equivalent Units","published_at":"2024-07-02T20:20:00.000Z","date":"2024-06-30","kind":"grant","planned":false,"acquired":true,"shares":225,"price":171.52,"value":38592.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":26170,"derivative":{"exercise_price":171.52,"underlying":"Common Stock","underlying_shares":225},"source":{"system":"sec-edgar","filing":"0000897069-24-001473","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000089706924001473/form4.xml","form_type":"4"}},{"id":41198,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.01 par value","published_at":"2024-05-07T22:30:49.000Z","date":"2024-05-03","kind":"grant","planned":false,"acquired":true,"shares":1322,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These are restricted stock units awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program (the \"Program\"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."}],"balance_after":31356,"source":{"system":"sec-edgar","filing":"0001415889-24-012528","document":"form4-05072024_100531.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000141588924012528/form4-05072024_100531.xml","form_type":"4"}},{"id":1542696,"issuer":{"id":7263,"kind":"organization","name":"Xos, Inc.","symbol":"XOS"},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-12T22:14:59.000Z","date":"2024-04-10","kind":"grant","planned":false,"acquired":true,"shares":445,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares reported in this transaction represent Restricted Stock Units (\"RSUs\"). The RSUs reported vested immediately on the date of grant. The RSUs were issued to the director in lieu of their cash retainer for the director's service in Q1 2024. Each RSU represents a contingent right to receive one share of common stock upon settlement."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 15,450 unvested RSUs. Each RSU represents a contingent right to receive one share of common stock upon settlement."}],"balance_after":24558,"source":{"system":"sec-edgar","filing":"0001819493-24-000052","document":"wk-form4_1712960091.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000181949324000052/wk-form4_1712960091.xml","form_type":"4"}},{"id":42130,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2024-04-02T21:00:12.000Z","date":"2024-03-31","kind":"grant","planned":false,"acquired":true,"shares":212,"price":182.1,"value":38605.2,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":25701,"derivative":{"exercise_price":182.1,"underlying":"Common Stock","underlying_shares":212},"source":{"system":"sec-edgar","filing":"0001415889-24-009801","document":"form4-04022024_050405.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000141588924009801/form4-04022024_050405.xml","form_type":"4"}},{"id":1678170,"issuer":{"id":7263,"kind":"organization","name":"Xos, Inc.","symbol":"XOS"},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-17T21:13:06.000Z","date":"2024-01-15","kind":"grant","planned":false,"acquired":true,"shares":650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares reported in this transaction represent Restricted Stock Units (\"RSUs\"). The RSUs reported vested immediately on the date of grant. The RSUs were issued to the director in lieu of their cash retainer for the director's service in Q4 2023. Each RSU represents a contingent right to receive one share of common stock upon settlement."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On December 6th, the common stock of Xos, Inc. reverse split 1-for-30, resulting in a decrease of 680,452 shares in the reporting person's ownership of common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 15,450 unvested RSUs."}],"balance_after":24113,"source":{"system":"sec-edgar","filing":"0001819493-24-000012","document":"wk-form4_1705525972.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000181949324000012/wk-form4_1705525972.xml","form_type":"4"}},{"id":48932,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2024-01-03T22:00:29.000Z","date":"2023-12-31","kind":"grant","planned":false,"acquired":true,"shares":250,"price":154.97,"value":38742.5,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":25266,"derivative":{"exercise_price":154.97,"underlying":"Common Stock","underlying_shares":250},"source":{"system":"sec-edgar","filing":"0001415889-24-000327","document":"form4-01032024_050102.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000141588924000327/form4-01032024_050102.xml","form_type":"4"}},{"id":1761255,"issuer":{"id":7263,"kind":"organization","name":"Xos, Inc.","symbol":"XOS"},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-12T20:14:04.000Z","date":"2023-10-10","kind":"grant","planned":false,"acquired":true,"shares":15151,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares reported in this transaction represent Restricted Stock Units (\"RSUs\"). The RSUs reported vested immediately on the date of grant. The RSUs were issued to the director in lieu of their cash retainer for the director's service in Q3 2023 and calculated as of October 10, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 482,597 unvested RSUs. Each RSU represents a contingent right to receive one share of common stock upon settlement."}],"balance_after":703915,"source":{"system":"sec-edgar","filing":"0001819493-23-000239","document":"wk-form4_1697141635.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000181949323000239/wk-form4_1697141635.xml","form_type":"4"}},{"id":52235,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2023-10-03T21:00:34.000Z","date":"2023-09-30","kind":"grant","planned":false,"acquired":true,"shares":259,"price":149.06,"value":38606.54,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":24750,"derivative":{"exercise_price":149.06,"underlying":"Common Stock","underlying_shares":259},"source":{"system":"sec-edgar","filing":"0001415889-23-013896","document":"form4-10032023_051004.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000141588923013896/form4-10032023_051004.xml","form_type":"4"}},{"id":1830444,"issuer":{"id":7263,"kind":"organization","name":"Xos, Inc.","symbol":"XOS"},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-13T22:46:03.000Z","date":"2023-07-12","kind":"grant","planned":false,"acquired":true,"shares":15151,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares reported in this transaction represent Restricted Stock Units (\"RSUs\"). The RSUs reported vested immediately on the date of grant. The RSUs were issued to the director in lieu of their cash retainer for the director's service in Q2 2023 and calculated as of July 11, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 482,597 unvested RSUs. Each RSU represents a contingent right to receive one share of common stock upon settlement."}],"balance_after":688764,"source":{"system":"sec-edgar","filing":"0001819493-23-000190","document":"wf-form4_168928835313890.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000181949323000190/wf-form4_168928835313890.xml","form_type":"4"}},{"id":54529,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2023-07-05T21:00:15.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":287,"price":134.73,"value":38667.51,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":24254,"derivative":{"exercise_price":134.73,"underlying":"Common Stock","underlying_shares":287},"source":{"system":"sec-edgar","filing":"0001415889-23-010774","document":"form4-07052023_050703.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000141588923010774/form4-07052023_050703.xml","form_type":"4"}},{"id":1856159,"issuer":{"id":7263,"kind":"organization","name":"Xos, Inc.","symbol":"XOS"},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-14T20:12:22.000Z","date":"2023-06-12","kind":"grant","planned":false,"acquired":true,"shares":444444,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares reported in this transaction represent Restricted Stock Units (\"RSUs\"). The RSUs vest on the earlier of (i) the first anniversary of the Grant date and (ii) the day of the Company's 2024 Annual Meeting, subject to the Reporting Person's continuous service with Xos, Inc. through the vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 482,597 unvested RSUs. Each RSU represents a contingent right to receive one share of common stock upon settlement."}],"balance_after":673613,"source":{"system":"sec-edgar","filing":"0001819493-23-000142","document":"wf-form4_168677352703877.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000181949323000142/wf-form4_168677352703877.xml","form_type":"4"}},{"id":56065,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.01 par value","published_at":"2023-05-09T21:03:56.000Z","date":"2023-05-05","kind":"grant","planned":false,"acquired":true,"shares":1450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These are restricted stock units awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program (the \"Program\"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."}],"balance_after":30034,"source":{"system":"sec-edgar","filing":"0001415889-23-007674","document":"form4-05092023_090547.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000141588923007674/form4-05092023_090547.xml","form_type":"4"}},{"id":56814,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2023-04-04T21:00:21.000Z","date":"2023-03-31","kind":"grant","planned":false,"acquired":true,"shares":243,"price":159.37,"value":38726.91,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":23727,"derivative":{"exercise_price":159.37,"underlying":"Common Stock","underlying_shares":243},"source":{"system":"sec-edgar","filing":"0001415889-23-006073","document":"form4-04042023_050401.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000141588923006073/form4-04042023_050401.xml","form_type":"4"}},{"id":1929154,"issuer":{"id":7263,"kind":"organization","name":"Xos, Inc.","symbol":"XOS"},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-04T20:32:23.000Z","date":"2023-04-03","kind":"grant","planned":false,"acquired":true,"shares":7936,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares reported in this transaction represent Restricted Stock Units (\"RSUs\"). The RSUs reported vested immediately on the date of grant. The RSUs were issued to the director in lieu of their cash retainer for the director's service in Q1 2023 and calculated as of March 31, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 153,759 unvested RSUs. Each RSU represents a contingent right to receive one share of common stock upon settlement."}],"balance_after":229169,"source":{"system":"sec-edgar","filing":"0001819493-23-000068","document":"wf-form4_168064032451432.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000181949323000068/wf-form4_168064032451432.xml","form_type":"4"}},{"id":2055790,"issuer":{"id":7263,"kind":"organization","name":"Xos, Inc.","symbol":"XOS"},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-12T21:33:12.000Z","date":"2023-01-10","kind":"grant","acquired":true,"shares":7936,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares reported in this transaction represent Restricted Stock Units (\"RSUs\"). The RSUs reported vested immediately on the date of grant. The RSUs were issued to the director in lieu of their cash retainer for the director's service in Q4 2022 and calculated as of December 31, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 153,759 unvested RSUs. Each RSU represents a contingent right to receive one share of common stock upon settlement."}],"balance_after":521233,"source":{"system":"sec-edgar","filing":"0001819493-23-000015","document":"wf-form4_167355917054636.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000181949323000015/wf-form4_167355917054636.xml","form_type":"4"}},{"id":60393,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2023-01-03T22:05:16.000Z","date":"2022-12-31","kind":"grant","acquired":true,"shares":239,"price":161.61,"value":38624.79,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":23256,"derivative":{"exercise_price":161.61,"underlying":"Common Stock","underlying_shares":239},"source":{"system":"sec-edgar","filing":"0001415889-23-000086","document":"form4-01032023_100105.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000141588923000086/form4-01032023_100105.xml","form_type":"4"}},{"id":2098684,"issuer":{"id":7263,"kind":"organization","name":"Xos, Inc.","symbol":"XOS"},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-12-02T21:21:16.000Z","date":"2022-11-30","kind":"purchase","acquired":true,"shares":300000,"price":0.69,"value":207000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 153,759 unvested RSUs. Each RSU represents a contingent right to receive one share of common stock upon settlement."}],"balance_after":513297,"source":{"system":"sec-edgar","filing":"0001819493-22-000174","document":"wf-form4_167001605632738.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000181949322000174/wf-form4_167001605632738.xml","form_type":"4"}},{"id":62892,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2022-10-04T21:08:42.000Z","date":"2022-09-30","kind":"grant","acquired":true,"shares":288,"price":134.21,"value":38652.48,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":22806,"derivative":{"exercise_price":134.21,"underlying":"Common Stock","underlying_shares":288},"source":{"system":"sec-edgar","filing":"0001415889-22-010247","document":"form4-10042022_021024.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000141588922010247/form4-10042022_021024.xml","form_type":"4"}},{"id":2145238,"issuer":{"id":7263,"kind":"organization","name":"Xos, Inc.","symbol":"XOS"},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-10-04T20:10:31.000Z","date":"2022-09-30","kind":"grant","acquired":true,"shares":3378,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares reported in this transaction represent Restricted Stock Units (\"RSUs\"). The RSUs reported vested immediately on the date of grant. The RSUs were issued to the director in lieu of their cash retainer for the director's service in Q3 2022 and calculated as of September 30, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 172,835 unvested RSUs. Each RSU represents a contingent right to receive one share of common stock upon settlement."}],"balance_after":213297,"source":{"system":"sec-edgar","filing":"0001819493-22-000129","document":"wf-form4_166491420871053.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000181949322000129/wf-form4_166491420871053.xml","form_type":"4"}},{"id":2159517,"issuer":{"id":7263,"kind":"organization","name":"Xos, Inc.","symbol":"XOS"},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-09-14T20:03:59.000Z","date":"2022-09-12","kind":"grant","acquired":true,"shares":115606,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares reported in this transaction represent Restricted Stock Units (\"RSUs\"). The restricted stock units vest on the earlier of (i) the first anniversary of the Grant Date and (ii) the day before the next annual meeting of Xos, Inc. following the Grant Date, subject to the Reporting Person's continuous service with Xos, Inc. through the vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 172,835 unvested RSUs. Each RSU represents a contingent right to receive one share of common stock upon settlement."}],"balance_after":209919,"source":{"system":"sec-edgar","filing":"0001819493-22-000101","document":"wf-form4_166318582141294.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000181949322000101/wf-form4_166318582141294.xml","form_type":"4"}},{"id":2193559,"issuer":{"id":7263,"kind":"organization","name":"Xos, Inc.","symbol":"XOS"},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-05T20:30:16.000Z","date":"2022-08-03","kind":"grant","acquired":true,"shares":3816,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares reported in this transaction represent Restricted Stock Units (\"RSUs\"). The RSUs reported vested immediately on the date of grant. The RSUs were issued to the director in lieu of their cash retainer. 1,908 RSUs were issued for the director's service in Q1 2022 and calculated as of March 31, 2022. 1,908 RSUs were issued for the director's service in Q2 2022 and calculated as of June 30, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 57,229 unvested RSUs. Each RSU represents a contingent right to receive one share of common stock uponsettlement."}],"balance_after":94313,"source":{"system":"sec-edgar","filing":"0001819493-22-000063","document":"wf-form4_165973138668210.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000181949322000063/wf-form4_165973138668210.xml","form_type":"4"}},{"id":64975,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2022-07-05T21:23:26.000Z","date":"2022-06-30","kind":"grant","acquired":true,"shares":237,"price":153.16,"value":36298.92,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":22296,"derivative":{"exercise_price":153.16,"underlying":"Common Stock","underlying_shares":237},"source":{"system":"sec-edgar","filing":"0001415889-22-007379","document":"form4-07052022_020714.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000141588922007379/form4-07052022_020714.xml","form_type":"4"}},{"id":66484,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.01 par value","published_at":"2022-05-09T21:13:27.000Z","date":"2022-05-06","kind":"grant","acquired":true,"shares":1421,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These are restricted stock units awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program (the \"Program\"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."}],"balance_after":28584,"source":{"system":"sec-edgar","filing":"0001179110-22-002930","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000117911022002930/edgar.xml","form_type":"4"}},{"id":67979,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2022-04-04T21:15:17.000Z","date":"2022-03-31","kind":"grant","acquired":true,"shares":217,"price":162.11,"value":35177.87,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":21860,"derivative":{"exercise_price":162.11,"underlying":"Common Stock","underlying_shares":217},"source":{"system":"sec-edgar","filing":"0001179110-22-002545","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000117911022002545/edgar.xml","form_type":"4"}},{"id":73621,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2022-01-04T22:02:41.000Z","date":"2021-12-31","kind":"grant","acquired":true,"shares":260,"price":135.4,"value":35204.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":21434,"derivative":{"exercise_price":135.4,"underlying":"Common Stock","underlying_shares":260},"source":{"system":"sec-edgar","filing":"0001179110-22-000119","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000117911022000119/edgar.xml","form_type":"4"}},{"id":2450144,"issuer":{"id":7263,"kind":"organization","name":"Xos, Inc.","symbol":"XOS"},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-04T21:52:15.000Z","date":"2021-12-31","kind":"grant","acquired":true,"shares":1474,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares reported in this transaction represent Restricted Stock Units (\"RSUs\"). The RSUs reported vested immediately on the date of grant. The RSUs were issued to the director in lieu of their cash retainer."}],"balance_after":1474,"source":{"system":"sec-edgar","filing":"0001209191-22-000914","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000120919122000914/doc4.xml","form_type":"4"}},{"id":2501204,"issuer":{"id":7263,"kind":"organization","name":"Xos, Inc.","symbol":"XOS"},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-22T22:42:22.000Z","date":"2021-11-18","kind":"purchase","acquired":true,"shares":100000,"price":4.2682,"value":426820.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares are held by the Edward Joseph Rapp TTEE U/A DTD 02/07/2005, of which the Reporting Person is trustee."}],"balance_after":335169,"source":{"system":"sec-edgar","filing":"0001209191-21-066161","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000120919121066161/doc4.xml","form_type":"4"}},{"id":2513204,"issuer":{"id":7263,"kind":"organization","name":"Xos, Inc.","symbol":"XOS"},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2021-11-15T23:37:10.000Z","date":"2021-11-10","kind":"grant","acquired":true,"shares":31794,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The price is N/A."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price is N/A."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest on the earlier of (i) the first anniversary of the Grant Date and (ii) the day before the next annual meeting of Xos, Inc. following the Grant Date, subject to such individual's continuous service with Xos, Inc. through the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Date is N/A."}],"balance_after":31794,"derivative":{"underlying":"Common Stock","underlying_shares":31794},"source":{"system":"sec-edgar","filing":"0001209191-21-064558","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000120919121064558/doc4.xml","form_type":"4"}},{"id":2513203,"issuer":{"id":7263,"kind":"organization","name":"Xos, Inc.","symbol":"XOS"},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2021-11-15T23:37:10.000Z","date":"2021-11-10","kind":"grant","acquired":true,"shares":57229,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The price is N/A."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price is N/A."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in a series of three equal annual installments on each of the first, second and third year anniversaries of the grant date of November 10, 2021 (the \"Grant Date\"), subject to such individual's continuous service with Xos, Inc. through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Date is N/A."}],"balance_after":57229,"derivative":{"underlying":"Common Stock","underlying_shares":57229},"source":{"system":"sec-edgar","filing":"0001209191-21-064558","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000120919121064558/doc4.xml","form_type":"4"}},{"id":79731,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2021-10-04T21:04:57.000Z","date":"2021-09-30","kind":"grant","acquired":true,"shares":326,"price":107.87,"value":35165.62,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":20941,"derivative":{"exercise_price":107.87,"underlying":"Common Stock","underlying_shares":326},"source":{"system":"sec-edgar","filing":"0001179110-21-009162","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000117911021009162/edgar.xml","form_type":"4"}},{"id":2582056,"issuer":{"id":7263,"kind":"organization","name":"Xos, Inc.","symbol":"XOS"},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-02T20:30:13.000Z","date":"2021-09-01","kind":"purchase","acquired":true,"shares":5000,"price":6.65,"value":33250.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents weighted average purchase price. The shares were purchased at prices ranging from $6.635 to $6.65. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares purchased at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held by Edward Joseph Rapp TTEE U/A DTD 02/07/2005."}],"balance_after":235169,"source":{"system":"sec-edgar","filing":"0001209191-21-054443","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000120919121054443/doc4.xml","form_type":"4"}},{"id":2592607,"issuer":{"id":7263,"kind":"organization","name":"Xos, Inc.","symbol":"XOS"},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-24T21:05:47.000Z","date":"2021-08-20","kind":"grant","acquired":true,"shares":230169,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Received pursuant to the Agreement and Plan of Merger, dated as of February 21, 2021, as amended on May 14, 2021, by and among NextGen Acquisition Corporation (\"Acquiror\"), Sky Merger Sub I, Inc., a Delaware corporation and wholly owned subsidiary of Acquiror (\"Merger Sub\") and Xos, Inc. (\"Xos\"), pursuant to which Merger Sub was merged with and into Xos, whereupon the separate existence of Merger Sub ceased and Xos became the surviving company and continued in existence as a subsidiary of Acquiror, which subsequently changed its name to Xos, Inc. (the \"Issuer\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Received pursuant to the Agreement and Plan of Merger, dated as of February 21, 2021, as amended on May 14, 2021, by and among NextGen Acquisition Corporation (\"Acquiror\"), Sky Merger Sub I, Inc., a Delaware corporation and wholly owned subsidiary of Acquiror (\"Merger Sub\") and Xos, Inc. (\"Xos\"), pursuant to which Merger Sub was merged with and into Xos, whereupon the separate existence of Merger Sub ceased and Xos became the surviving company and continued in existence as a subsidiary of Acquiror, which subsequently changed its name to Xos, Inc. (the \"Issuer\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held by Edward Joseph Rapp TTEE U/A DTD 02/07/2005."}],"balance_after":230169,"source":{"system":"sec-edgar","filing":"0001209191-21-053171","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000120919121053171/doc4.xml","form_type":"4"}},{"id":84913,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2021-07-02T13:09:51.000Z","date":"2021-06-30","kind":"grant","acquired":true,"shares":312,"price":112.67,"value":35153.04,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":20390,"derivative":{"exercise_price":112.67,"underlying":"Common Stock","underlying_shares":312},"source":{"system":"sec-edgar","filing":"0001179110-21-007284","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000117911021007284/edgar.xml","form_type":"4"}},{"id":87964,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.01 par value","published_at":"2021-05-11T21:06:59.000Z","date":"2021-05-07","kind":"grant","acquired":true,"shares":1681,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the \"Program\"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."}],"balance_after":27163,"source":{"system":"sec-edgar","filing":"0001179110-21-005206","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000117911021005206/edgar.xml","form_type":"4"}},{"id":90178,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2021-04-01T20:43:08.000Z","date":"2021-03-31","kind":"grant","acquired":true,"shares":325,"price":108.22,"value":35171.5,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":19855,"derivative":{"exercise_price":108.22,"underlying":"Common Stock","underlying_shares":325},"source":{"system":"sec-edgar","filing":"0001179110-21-003954","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000117911021003954/edgar.xml","form_type":"4"}},{"id":95957,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2021-01-05T22:00:52.000Z","date":"2020-12-31","kind":"grant","acquired":true,"shares":328,"price":107.05,"value":35112.4,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":19289,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":328},"source":{"system":"sec-edgar","filing":"0001179110-21-000193","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000117911021000193/edgar.xml","form_type":"4"}},{"id":100588,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2020-10-02T20:53:51.000Z","date":"2020-09-30","kind":"grant","acquired":true,"shares":402,"price":87.59,"value":35211.18,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":18735,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":402},"source":{"system":"sec-edgar","filing":"0001179110-20-010199","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000117911020010199/edgar.xml","form_type":"4"}},{"id":100587,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.01 par value","published_at":"2020-10-02T20:53:51.000Z","date":"2020-09-03","kind":"gift","acquired":true,"shares":7513,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By spouse in trust"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reporting person disclaims beneficial ownership of all securities held by his wife."}],"balance_after":10388,"source":{"system":"sec-edgar","filing":"0001179110-20-010199","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000117911020010199/edgar.xml","form_type":"4"}},{"id":100586,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.01 par value","published_at":"2020-10-02T20:53:51.000Z","date":"2020-09-03","kind":"gift","acquired":false,"shares":7513,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":25482,"source":{"system":"sec-edgar","filing":"0001179110-20-010199","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000117911020010199/edgar.xml","form_type":"4"}},{"id":103543,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2020-07-02T13:32:43.000Z","date":"2020-06-30","kind":"grant","acquired":true,"shares":350,"price":98.18,"value":34363.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":18108,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":350},"source":{"system":"sec-edgar","filing":"0001179110-20-007841","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000117911020007841/edgar.xml","form_type":"4"}},{"id":104905,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.01 par value","published_at":"2020-05-12T21:07:23.000Z","date":"2020-05-08","kind":"grant","acquired":true,"shares":2333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the \"Program\"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the \"Program\"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."}],"balance_after":32995,"source":{"system":"sec-edgar","filing":"0001179110-20-005791","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000117911020005791/edgar.xml","form_type":"4"}},{"id":105743,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2020-04-02T21:03:18.000Z","date":"2020-03-31","kind":"grant","acquired":true,"shares":446,"price":76.19,"value":33980.74,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":17530,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":446},"source":{"system":"sec-edgar","filing":"0001179110-20-004520","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000117911020004520/edgar.xml","form_type":"4"}},{"id":106491,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.01 par value","published_at":"2020-03-04T22:14:48.000Z","date":"2020-03-03","kind":"purchase","acquired":true,"shares":2875,"price":87.8668,"value":252617.05,"ownership":{"direct":false,"nature":"By spouse in trust"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reporting person disclaims beneficial ownership of these securities."}],"balance_after":2875,"source":{"system":"sec-edgar","filing":"0001179110-20-003102","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000117911020003102/edgar.xml","form_type":"4"}},{"id":109420,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2020-01-03T17:39:22.000Z","date":"2019-12-31","kind":"grant","acquired":true,"shares":384,"price":88.54,"value":33999.36,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":16872,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":384},"source":{"system":"sec-edgar","filing":"0001179110-20-000103","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000117911020000103/edgar.xml","form_type":"4"}},{"id":112349,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2019-10-01T21:55:27.000Z","date":"2019-09-30","kind":"grant","acquired":true,"shares":449,"price":75.72,"value":33998.28,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":16291,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":449},"source":{"system":"sec-edgar","filing":"0001104659-19-052314","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000110465919052314/a4.xml","form_type":"4"}},{"id":115541,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2019-07-02T17:13:06.000Z","date":"2019-06-30","kind":"grant","acquired":true,"shares":467,"price":72.72,"value":33960.24,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":15577,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":467},"source":{"system":"sec-edgar","filing":"0001179110-19-008306","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000117911019008306/edgar.xml","form_type":"4"}},{"id":115663,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.01 par value","published_at":"2019-06-28T20:48:25.000Z","date":"2019-06-26","kind":"purchase","acquired":true,"shares":7500,"price":67.3,"value":504750.0,"ownership":{"direct":true},"balance_after":30662,"source":{"system":"sec-edgar","filing":"0001179110-19-008216","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000117911019008216/edgar.xml","form_type":"4"}},{"id":116866,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.01 par value","published_at":"2019-05-07T20:54:27.000Z","date":"2019-05-03","kind":"grant","acquired":true,"shares":2419,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the \"Program\"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the \"Program\"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."}],"balance_after":23162,"source":{"system":"sec-edgar","filing":"0001179110-19-005672","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000117911019005672/edgar.xml","form_type":"4"}},{"id":117889,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2019-04-02T21:06:04.000Z","date":"2019-03-31","kind":"grant","acquired":true,"shares":421,"price":80.59,"value":33928.39,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":14907,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":421},"source":{"system":"sec-edgar","filing":"0001179110-19-004527","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000117911019004527/edgar.xml","form_type":"4"}},{"id":121387,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2019-01-03T21:50:48.000Z","date":"2018-12-31","kind":"grant","acquired":true,"shares":368,"price":92.19,"value":33925.92,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":14296,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":368},"source":{"system":"sec-edgar","filing":"0001179110-19-000232","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000117911019000232/edgar.xml","form_type":"4"}},{"id":124050,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2018-10-02T18:07:10.000Z","date":"2018-09-30","kind":"grant","acquired":true,"shares":359,"price":94.58,"value":33954.22,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":13780,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":359},"source":{"system":"sec-edgar","filing":"0001179110-18-011830","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000117911018011830/edgar.xml","form_type":"4"}},{"id":127226,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2018-07-02T20:39:46.000Z","date":"2018-06-30","kind":"grant","acquired":true,"shares":357,"price":92.65,"value":33076.05,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":13290,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":357},"source":{"system":"sec-edgar","filing":"0001179110-18-009206","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000117911018009206/edgar.xml","form_type":"4"}},{"id":127455,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, $0.01 par value","published_at":"2018-06-22T21:56:46.000Z","date":"2018-06-20","kind":"purchase","acquired":true,"shares":1013,"price":98.6266,"value":99908.7458,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This Form 4 also updates the number of securities beneficially owned by the reporting person, which was understated on the Forms 4 filed August 2, 2017 and May 7, 2018."}],"balance_after":20743,"source":{"system":"sec-edgar","filing":"0001179110-18-008967","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000117911018008967/edgar.xml","form_type":"4"}},{"id":129142,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, $0.01 par value","published_at":"2018-05-08T00:28:08.000Z","date":"2018-05-04","kind":"grant","acquired":true,"shares":1899,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the \"Program\"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the \"Program\"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."}],"balance_after":17629,"source":{"system":"sec-edgar","filing":"0001179110-18-006409","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000117911018006409/edgar.xml","form_type":"4"}},{"id":130267,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2018-04-02T17:53:17.000Z","date":"2018-03-31","kind":"grant","acquired":true,"shares":346,"price":94.65,"value":32748.9,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":12814,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":346},"source":{"system":"sec-edgar","filing":"0001179110-18-005007","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000117911018005007/edgar.xml","form_type":"4"}},{"id":134053,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2018-01-03T22:05:47.000Z","date":"2017-12-31","kind":"grant","acquired":true,"shares":338,"price":96.71,"value":32687.98,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":12391,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":338},"source":{"system":"sec-edgar","filing":"0001179110-18-000329","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000117911018000329/edgar.xml","form_type":"4"}},{"id":136681,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2017-10-03T20:32:51.000Z","date":"2017-09-30","kind":"grant","acquired":true,"shares":368,"price":88.86,"value":32700.48,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":11971,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":368},"source":{"system":"sec-edgar","filing":"0001179110-17-012956","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000117911017012956/edgar.xml","form_type":"4"}},{"id":138522,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.01 par value","published_at":"2017-08-02T21:05:27.000Z","date":"2017-07-31","kind":"purchase","acquired":true,"shares":4000,"price":70.4455,"value":281782.0,"ownership":{"direct":true},"balance_after":15498,"source":{"system":"sec-edgar","filing":"0001179110-17-010981","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000117911017010981/edgar.xml","form_type":"4"}},{"id":139166,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2017-07-05T15:39:30.000Z","date":"2017-06-30","kind":"grant","acquired":true,"shares":451,"price":72.51,"value":32702.01,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":11498,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":451},"source":{"system":"sec-edgar","filing":"0001179110-17-009954","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000117911017009954/edgar.xml","form_type":"4"}},{"id":140813,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, $0.01 par value","published_at":"2017-05-09T21:23:09.000Z","date":"2017-05-05","kind":"grant","acquired":true,"shares":2770,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the \"Program\"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the \"Program\"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."}],"balance_after":15730,"source":{"system":"sec-edgar","filing":"0001179110-17-006929","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000117911017006929/edgar.xml","form_type":"4"}},{"id":141597,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2017-04-04T21:31:21.000Z","date":"2017-03-31","kind":"grant","acquired":true,"shares":502,"price":65.16,"value":32710.32,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":10941,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":502},"source":{"system":"sec-edgar","filing":"0001179110-17-005606","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000117911017005606/edgar.xml","form_type":"4"}},{"id":145302,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2017-01-04T22:32:23.000Z","date":"2016-12-31","kind":"grant","acquired":true,"shares":523,"price":62.62,"value":32750.26,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":10331,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":523},"source":{"system":"sec-edgar","filing":"0001179110-17-000300","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000117911017000300/edgar.xml","form_type":"4"}},{"id":148336,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2016-10-04T21:46:07.000Z","date":"2016-09-30","kind":"grant","acquired":true,"shares":519,"price":63.07,"value":32733.33,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":9720,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":519},"source":{"system":"sec-edgar","filing":"0001179110-16-030341","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000117911016030341/edgar.xml","form_type":"4"}},{"id":151087,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2016-07-15T23:52:25.000Z","date":"2016-06-30","kind":"grant","acquired":true,"shares":531,"price":61.91,"value":32874.21,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":9124,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":531},"source":{"system":"sec-edgar","filing":"0001179110-16-027685","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000117911016027685/edgar.xml","form_type":"4"}},{"id":152919,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, $0.01 par value","published_at":"2016-05-10T21:24:31.000Z","date":"2016-05-06","kind":"grant","acquired":true,"shares":2974,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the \"Program\"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the \"Program\"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."}],"balance_after":12960,"source":{"system":"sec-edgar","filing":"0001179110-16-024269","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000117911016024269/edgar.xml","form_type":"4"}},{"id":154119,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2016-04-04T21:19:13.000Z","date":"2016-03-31","kind":"grant","acquired":true,"shares":577,"price":57.12,"value":32958.24,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":8514,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":577},"source":{"system":"sec-edgar","filing":"0001179110-16-022684","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000117911016022684/edgar.xml","form_type":"4"}},{"id":154905,"issuer":{"id":2808,"kind":"organization","name":"CATERPILLAR INC","symbol":"CAT"},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Group President"}}],"security":"Employee Stock Option","published_at":"2016-03-09T20:15:48.000Z","date":"2016-03-07","kind":"grant","acquired":true,"shares":114049,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options were granted pursuant to the Caterpillar Inc. 2014 Long-Term Incentive Plan and vest equally in 1/3 increments beginning on the first anniversary of the grant date."}],"balance_after":114049,"derivative":{"exercise_price":74.77,"expiration_date":"2026-03-07","underlying":"Common Stock","underlying_shares":114049},"source":{"system":"sec-edgar","filing":"0000018230-16-000436","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/18230/000001823016000436/edgar.xml","form_type":"4"}},{"id":157950,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2016-01-05T22:13:41.000Z","date":"2015-12-31","kind":"grant","acquired":true,"shares":557,"price":59.24,"value":32996.68,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":7853,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":557},"source":{"system":"sec-edgar","filing":"0001179110-16-017101","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000117911016017101/edgar.xml","form_type":"4"}},{"id":160928,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2015-10-02T20:48:35.000Z","date":"2015-09-30","kind":"grant","acquired":true,"shares":606,"price":54.41,"value":32972.46,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":7234,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":606},"source":{"system":"sec-edgar","filing":"0001179110-15-013706","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000117911015013706/edgar.xml","form_type":"4"}},{"id":163012,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2015-07-02T20:57:12.000Z","date":"2015-06-30","kind":"grant","acquired":true,"shares":491,"price":67.19,"value":32990.29,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":6579,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":491},"source":{"system":"sec-edgar","filing":"0001179110-15-010805","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000117911015010805/edgar.xml","form_type":"4"}},{"id":164002,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, $0.01 par value","published_at":"2015-05-12T21:52:55.000Z","date":"2015-05-08","kind":"grant","acquired":true,"shares":2187,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the \"Program\"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the \"Program\"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."}],"balance_after":9986,"source":{"system":"sec-edgar","filing":"0001179110-15-007670","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1171780/000117911015007670/edgar.xml","form_type":"4"}},{"id":164234,"issuer":{"id":2808,"kind":"organization","name":"CATERPILLAR INC","symbol":"CAT"},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Group President"}}],"security":"Restricted Stock Units","published_at":"2015-05-05T21:34:01.000Z","date":"2015-05-02","kind":"exercise","acquired":false,"shares":334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (RSU) represents the right to receive one share of Caterpillar Inc. common stock upon vesting of such RSUs."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"RSUs vest in three equal annual installments beginning on May 2, 2014. On May 2, 2015, the reporting person's RSUs were settled for an equal number of shares of Caterpillar Inc. common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"RSUs vest in three equal annual installments beginning on May 2, 2014. On May 2, 2015, the reporting person's RSUs were settled for an equal number of shares of Caterpillar Inc. common stock."}],"balance_after":332,"derivative":{"underlying":"Common Stock","underlying_shares":334},"source":{"system":"sec-edgar","filing":"0000018230-15-000169","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/18230/000001823015000169/edgar.xml","form_type":"4"}},{"id":164233,"issuer":{"id":2808,"kind":"organization","name":"CATERPILLAR INC","symbol":"CAT"},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Group President"}}],"security":"Common Stock","published_at":"2015-05-05T21:34:01.000Z","date":"2015-05-02","kind":"tax_withholding","acquired":false,"shares":153,"price":87.565,"value":13397.445,"ownership":{"direct":true},"balance_after":70315,"source":{"system":"sec-edgar","filing":"0000018230-15-000169","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/18230/000001823015000169/edgar.xml","form_type":"4"}},{"id":164232,"issuer":{"id":2808,"kind":"organization","name":"CATERPILLAR INC","symbol":"CAT"},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Group President"}}],"security":"Common Stock","published_at":"2015-05-05T21:34:01.000Z","date":"2015-05-01","kind":"tax_withholding","acquired":false,"shares":382,"price":87.52,"value":33432.64,"ownership":{"direct":true},"balance_after":70468,"source":{"system":"sec-edgar","filing":"0000018230-15-000169","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/18230/000001823015000169/edgar.xml","form_type":"4"}},{"id":164231,"issuer":{"id":2808,"kind":"organization","name":"CATERPILLAR INC","symbol":"CAT"},"owners":[{"id":10596,"kind":"person","name":"RAPP EDWARD J","position":1,"cik":"0001171780","reported_name":"RAPP EDWARD J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Group President"}}],"security":"Common Stock","published_at":"2015-05-05T21:34:01.000Z","date":"2015-05-02","kind":"exercise","acquired":true,"shares":334,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":70850,"source":{"system":"sec-edgar","filing":"0000018230-15-000169","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/18230/000001823015000169/edgar.xml","form_type":"4"}}],"next_cursor":"2015-05-05T21:34:01.000000Z,164231"}